To visit the main Medicines Optimisation Guidance page please click here.
New Oral Anticoagulants (NOAC)
The new oral Anticoagulants, Rivaroxaban, Dabigatran and Apixaban are now available for initiation in primary care and in limited circumstances for inpatients in secondary care. The drugs are grey listed and must be used within the criteria specified; the grey list can be accessed by clicking here.
A range of documents have been developed to support clinicians in considering these medications and help and support is available from the Medicines Management Team, either through the prescribing enquiry e-mail or via telephone on .
Individual summary of product characteristics can be accessed by searching on the drug name at this website -->http://www.medicines.org.uk/EMC -->
NOAC Documentation
- NHS Stockport NOAC guidance v1 2 2 July 14
- Referral pathway for NOAC drugs
- Record of Inititaion NOAC form July 2014
- Outpatient Flowchart
- Inpatient Flowchart
- Patient Counselling checklist v2
- Leaflet Rivaroxaban for DVT 2014
- Leaflet Dabigatran for AF 2014
- Leaflet Rivaroxaban in AF 2014
- Leaflet Apixaban in AF 2014
- Leaflet Rivaroxaban for PE
- NOAC transfer for DVT PE v1 May 15
- NOAC_transfer_process for AF patients v2 May 15
….. more documentation to follow
A Stroke Prevention Masterclass was held on the 11th October 2012. Members can view the documentation from this masterclass using the link below. This page is not publically available and members will need to login to view it.
- Stroke Prevention Masterclass 11th October 2012
